29268 Federal Register / Vol. 86, No. 103 / Tuesday, June 1, 2021 / Notices 

because the revisions are nonsubstantive; for example, we revised the 

CPGs’ formats to be consistent with 

other CPGs, included references to other 

aflatoxins CPGs, and included a 

reference to the Memorandum of 

Understanding between USDA/AMS 

and FDA. Given the minor nature of 

these revisions, an opportunity for 

public comment before we finalize the 

CPGs is unnecessary. However, as is the 

case for all guidance documents, the 

public may comment on any guidance 

document at any time (§ 10.115(g)(5)). 

The guidances represent the current 

thinking of FDA on this topic. They do 

not establish any rights for any person 

and are not binding on FDA or the 

public. You can use an alternative 

approach if it satisfies the requirements 

of the applicable statutes and 

regulations. 

These four CPGs update the 

previously issued ‘‘CPG Sec. 555.400 

Foods—Adulteration with Aflatoxin,’’ 

‘‘CPG Sec. 570.200 Brazil Nuts— 

Adulteration with Aflatoxin,’’ ‘‘CPG 

Sec. 570.375 Aflatoxin in Peanuts and 

Peanut Products,’’ and ‘‘CPG Sec. 

570.500 Pistachio Nuts—Aflatoxin 

Adulteration.’’ The CPGs are intended 

to provide guidance for FDA staff 

regarding adulteration in human food, 

Brazil nuts, peanuts and peanut 

products, and pistachio nuts due to the 

presence of aflatoxins and explain when 

we may consider such foods to be 

adulterated under section 402 of the 

Federal Food, Drug, and Cosmetic Act 

(21 U.S.C. 342). 

II. Paperwork Reduction Act of 1995 

These guidances contain no collection 

of information. Therefore, clearance by 

the Office of Management and Budget 

under the Paperwork Reduction Act of 

1995 is not required. 

III. Electronic Access 

Persons with access to the internet 

may obtain the guidances at either 

https://www.fda.gov/FoodGuidances or 

https://www.regulations.gov. Use the 

FDA website listed in the previous 

sentence to find the most current 

version of the guidances. 

Dated: May 24, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–11388 Filed 5–28–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier OS–0990–new] 

Agency Information Collection 

Request. 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before July 1, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990–New–30D and project title for 

reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Advancing the 

response to COVID–19 Learning 

Community Measure. 

Type of Collection: New. 

OMB No. 0990–NEW—Office within 

OS—OMH 

Abstract: The Department of Health 

and Human Services, Office of Minority 

Health (OMH) is seeking an approval by 

OMB on a new information collection, 

Advancing the response to COVID–19 

Learning Community Measure (hereafter 

COVID–19 Learning Community 

Measure). The purpose of this data 

collection is to gather quantitative and 

qualitative data from Learning 

Community members to monitor 

learning community performance in 

achieving process and outcome 

measures over the course of the one-year 

project. OMH will collect a set of 

process and outcome measures from 

program participants to assess the 

degree to which the learning community 

is effective in connecting subject matter 

experts and public health leaders, 

facilitating networking, and peer-to-peer 

information sharing of promising 

practices, programs, and/or policy. 

The OMB clearance will enable OMH 

to monitor and evaluate the COVID–19 

Learning Community performance. The 

data will be used to report the impact 

of the COVID–19 Learning Community. 

The ability to monitor and evaluate 

performance in this manner, and to 

work towards continuous program 

improvement are basic functions that 

OMH must be able to accomplish in 

order to carry out goals for the COVID– 

19 Learning Community and to ensure 

the most effective and appropriate use 

of resources. 

Likely Respondents: Members and 

staff from academia, community 

organizations, local/state/federal 

government, private sector, and tribal 

government and services who serve 

American Indian and Alaska Native 

and/or racial and ethnic minorities. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

COVID–19 Learning Community Members ..................................................... 200 1 5/60 17 

Total .......................................................................................................... ........................ ........................ ........................ 17 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 103 / Tuesday, June 1, 2021 / Notices 29269 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–11420 Filed 5–28–21; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; 

Integrative and Clinical Endocrinology and 

Reproduction Study Section. 

Date: June 23–24, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Dianne Hardy, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6175, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1154, dianne.hardy@nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Biobehavioral Mechanisms of 

Emotion, Stress and Health Study Section. 

Date: June 23–25, 2021. 

Time: 9:30 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maribeth Champoux, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7848, Bethesda, MD 20892, (301) 594– 

3163, champoum@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel PAR–20– 

211: Mid-Career Enhancement Awards to 

Integrate Basic Behavioral, Biomedical, and/ 

or Social Scientific Processes (K18 No 

Independent Clinical Trials). 

Date: June 23, 2021. 

Time: 4:30 p.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Maribeth Champoux, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3170, 

MSC 7848, Bethesda, MD 20892, 301–594– 

3163, champoum@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Endocrinology, Metabolism, 

Nutrition and Reproductive Sciences. 

Date: June 24, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yunshang Piao, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive Room 6184, 

Bethesda, MD 20892, 301–402–8402, 

piaoy3@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Instrumentation, Environmental, 

and Occupational Safety. 

Date: June 28–29, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joonil Seog, SCD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9791, joonil.seog@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; 

Pregnancy and Neonatology Study Section. 

Date: June 28–30, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Andrew Maxwell Wolfe, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, NIH, 6701 Rockledge Dr. 

Room 6214, Bethesda, MD 20892, 301–402– 

3019, andrew.wolfe@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business Applications: Drug Discovery and 

Development. 

Date: June 28–29, 2021. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sergei Ruvinov, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-Viral Anti-Infective 

Therapeutics. 

Date: June 29, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Bidyottam Mittra, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20894, 301–435–4057, bidyottam.mittra@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Musculoskeletal, Rehabilitation 

and Skin Sciences. 

Date: June 29–30, 2021. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Chi-Wing Chow, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4110, 

Bethesda, MD 20892, (301) 402–3912, 

chowc2@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Mechanisms 

of Disparities in Etiology and Outcomes of 

Lung Cancer. 

Date: June 29, 2021. 

Time: 1:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ola Mae Zack Howard, BS, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, 301–451– 

4467, howardz@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Academic Industrial Partnerships for 

Translation of Medical Technologies. 

Date: July 1–2, 2021 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Guo Feng Xu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, (301) 237– 

9870, xuguofen@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Endocrinology, Metabolism, 

Nutrition and Reproductive Sciences. 


jbell on DSKJLSW7X2PROD with NOTICES